Acta Med. 2022, 65: 89-98

https://doi.org/10.14712/18059694.2022.24

The Choroid after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

Evita Evangelia Christoua, Andreas Katsanosa, Ilias Georgalasb, Vassilios Kozobolisc, Christos Kalogeropoulosa, Maria Stefaniotoua

aDepartment of Ophthalmology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece
bFirst Department of Ophthalmology, General Hospital of Athens G. Gennimatas, Medical School, National and Kapodistrian University of Athens, Greece
cDepartment of Ophthalmology, Faculty of Medicine, School of Health Sciences, University of Patras, Patras, Greece

Received May 11, 2022
Accepted November 14, 2022

Crossref Cited-by Linking

  • Garg Sunir, Hadziahmetovic Majda: Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review. OPTH 2024, Volume 18, 1701. <https://doi.org/10.2147/OPTH.S464371>
Crossref Cited-by Linking logo